Our team assists with new WHO guidelines for treatment of hepatitis B -- read more here

Sen. Steven J. Santarsiero honored at the Pennsylvania Biotechnology Center (PABC)

The Bucks County legislator was presented with the first annual Timothy M. Block, PhD, Biotech Impact Award

Doylestown, Nov. 17, 2023 – The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) yesterday presented Sen. Steven J. Santarsiero, who represents residents of Bucks County, with the organizations’ first annual Timothy M. Block, PhD, Biotech Impact Award”.

The Senator was honored at the 23rd Annual Regional Biotechnology Conference at the PABC, which was attended by about 100 professionals in the life sciences, finance and related sectors. Along with the award, Sen. Santarsiero was presented with a personalized lab coat from the Blumberg Institute.

original 2FB9DCE4 58F0 421A 9C28 EE2C0B81EDF9

Louis P. Kassa III, CEO of the PABC, Blumberg and Hepatitis B Foundation (left), Sen. Steven J. Santarsiero (center) and Timothy M. Block, PhD, co-founder, former president and board chair of the Hepatitis B Foundation, Blumberg Institute and PABC.

Timothy M. Block, PhD, co-founder, former president and board chair of the Hepatitis B Foundation, Blumberg Institute and PABC thanked Sen. Santarsiero for being a strong supporter for many years.

“In Harrisburg, here in Bucks County and beyond, Sen Santarsiero been a hero for our cause and for technology development, and he has done it with such eloquence that he has now become one of the Commonwealth’s most effective advocates for how technology, job creation and science can be combined for the public good,” Dr. Block said. “Not only through legislation and public support for innovative programs, which amounts to millions of dollars, but through his intelligence, new ideas, compassion and personal drive. There is a real humanism in what he does and how he does it.”

Key Bank of Bucks County was the Presenting Sponsor for this year’s Regional Biotechnology Conference.

Proceeds from the event will support research at the Hepatitis B Foundation and Blumberg Institute.

About the Hepatitis B Foundation: We are the leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. Founded in 1991, the Hepatitis B Foundation is based in Doylestown, Pa., with offices in Washington, D.C., and Philadelphia. To learn more, go to www.hepb.org, read our blog at hepb.org/blog, follow us on Twitter, Instagram and Facebook (@hepbfoundation) or contact through info@hepb.org.

About the Baruch S. Blumberg Institute:  An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is a leading center for translational research in hepatitis B and liver cancer. The Institute supports drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease and liver cancer in an environment conducive to interaction, collaboration and focus. The Blumberg Institute is located in the Pennsylvania Biotechnology Center, which it manages, near Doylestown, Pa. Visit www.blumberginstitute.org and follow us on Twitter @BlumbergInstit1.

About the Pennsylvania Biotechnology Center (PABC): The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advance biotechnology, maximize synergies among nonprofit scientists and their commercial colleagues. The PABC has nearly 100 member companies and organizations, mostly small to mid-size science, research and pharmaceutical companies. Nearly 50 of those companies operate on the Doylestown campus, which is home to the Hepatitis B Foundation and the Blumberg Institute. The PABC also manages B+labs at Cira Centre, a new incubator in Philadelphia, in partnership with Brandywine Realty Trust. PABC companies have produced numerous FDA-approved drugs and medical devices, and a recent study found that the PABC’s economic impact exceeded $7.3 billion and created more than 1,100 new jobs during 2016-2021. Please visit our website and follow us on LinkedInInstagram, Twitter (@BiotechnologyPa) and Facebook.